Danaher Corp at JPMorgan Healthcare Conference Transcript
Okay. We're going to go ahead and kick it off. I'm Tycho Peterson from the life science team at JPMorgan. Welcome to day 2 of the conference. I'm here to introduce Danaher. We'll do a breakout right after in the Georgian Room across the hall.
With that, let me turn it over to Tom Joyce.
Thank you, Tycho, and thank you to the entire JPMorgan team for putting on what I know, again, will be a terrific conference. Thanks to all of you also for joining us, all of you who rose to the early bell this morning for the 8:00 session. We appreciate you all joining us.
Here are our forward-looking statements. Obviously, I will let you read those at your leisure. Maybe before we dive in, I think many of you probably saw the announcement that we put out yesterday. An announcement around a preliminary look at our fourth quarter. And as you saw from that announcement, and I'll recap here, appears that we had a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |